Drug Shortage Report for SANDOZ ORPHENADRINE
| Report ID | 210064 |
| Drug Identification Number | 02243559 |
| Brand name | SANDOZ ORPHENADRINE |
| Common or Proper name | ORPHENADRINE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | ORPHENADRINE CITRATE |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 PRT BO |
| ATC code | M03BC |
| ATC description | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-11-13 |
| Estimated end date | 2023-12-15 |
| Actual end date | 2023-12-04 |
| Shortage status | Resolved |
| Updated date | 2023-12-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-12-05 | English | Compare |
| v5 | 2023-12-04 | French | Compare |
| v4 | 2023-12-04 | English | Compare |
| v3 | 2023-11-14 | English | Compare |
| v2 | 2023-11-13 | French | Compare |
| v1 | 2023-11-13 | English | Compare |
Showing 1 to 6 of 6